Pharmaceutical intermediates, being integral parts in API production, are quite relevant in drug formulation. Growth in demand for such pharmaceutical intermediates has become considerably high and is on an increase because of the heightened prescription of generic drugs along with new product development within this domain. Pharmaceutical intermediates will remain critical going ahead, considering the increasing need in personalized medicines and biologics around the world.
Manufacturers of pharmaceutical intermediates contribute to the expansion of the economy through initiating job creation and technological developments. The more companies invest in research and development, the more innovation is driven by them; increased efficiency in production along with cost reduction benefits manufacturers and will further allow health care providers to offer cheaper treatment options thereby improving access to the medicines that are essential for the patients. High incidence of chronic diseases, aging population, and rising pharmaceutical demand - all are pushing for intermediates. Regulatory structure is changing the response to the need for quality and safety of those products, creating challenges, but opportunities for producers to differentiate themselves through compliance and quality assurance.
The pharmaceutical intermediates market is going to continue growing in the future. The production processes will be redesigned...
Our subscribers play a decisive role in finalization of our annual list of Top 10 Pharmaceutical Intermediates Manufacturers - 2024 by nominating those which have served them with excellence and are praiseworthy. If you feel there is a company that deserves to be on our annual list, do write to us about them mentioning their value proposition.
 | Aarti Pharmalabs | Focus on generic APIs, generic intermediates, and xanthine derivatives while providing CDMO services for the development and manufacturing of drug substances and new chemical entities for innovative pharmaceutical and biotechnology companies |
 | Biosynth | Provides an extensive portfolio of APIs and intermediates across multiple therapeutic areas, including anti-TB, antipsychotic, anti-emetic, anti-gout, cardiac, and veterinary products |
 | Connex Pharma | Manufacturer of specialty chemicals and intermediates such as HMDS, TMCS, HMDO, and CMIC serves a diverse range of sectors, including pharmaceuticals, agrochemicals, and electronics |
 | Lucent Drugs | Provides a diverse range of products and is quickly expanding to meet the demand for high-value pharmaceuticals, producing large volumes of APIs & intermediates for both Indian and international markets |
 | Saral Chemtech | Manufacturer, supplier and exporter of top-notch quality APIs and Pharma intermediates, including aceclofenac, diclofenac sodium, diclofenacpotassium, mefenamic acid, nimesulide, ornidazole and many products |
 | Saurav Chemicals | A dependable supplier & CDMO offers an extensive selection of APIs and advanced intermediates across multiple therapeutic areas, including NSAIDs, cardiology, anticholinergic agents, CNS treatments, anti-filarial medications, and more |
 | Shree Ganesh Remedies | The company goal is to produce and export high-quality pharmaceutical intermediates, bulk drugs, and specialty chemicals for pharmaceutical companies involved in research and product development |
 | Sudarshan Pharma | A manufacturer and supplier of pharmaceutical intermediates, the company has been serving the chemical industry for 25 years and provides a diverse range of options for its clients |
 | Sunmoon Pharmaceuticals | Specializes in manufacturing pharmaceutical materials, drug intermediates, and specialty chemical compounds, the company combines experienced professionals and young talent to serve the pharmaceutical and allied industrial sectors with high-quality products |
 | Vasudha Pharma | Engaged in the manufacturing of APIs and Pharma Intermediates for catering to the domestic as well as international market, the firm recognized the vital role of R&D for becoming successful in the generic market |
